NUVASIVE INC. overview

NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting PR Newswire SAN DIEGO, Aug. 30, 2023 SAN DIEGO , Aug. 30, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Scoliosis Research Society (SRS) as a double diamond sponsor and will attend the 58 th Annual...

NuVasive Announces Second Quarter 2023 Financial Results PR Newswire SAN DIEGO, Aug. 2, 2023 – U.S. Cervical continues to deliver greater than 20% year-over-year growth– – International net sales grew 6.8% as reported and 9.8% on a constant currency basis– SAN DIEGO , Aug. 2, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results PR Newswire SAN DIEGO, July 24, 2023 SAN DIEGO , July 24, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it will release its second quarter 2023 results on Wednesday, August 2, 2023 , after the close of the market. NuVasive will hold a conference call...

NuVasive Announces First Quarter 2023 Financial Results PR Newswire SAN DIEGO, May 10, 2023 – Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis – – U.S. cervical delivers sixth consecutive quarter of greater than 20% growth, driven by C360 and the Simplify Cervical Disc– SAN DIEGO , May 10, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with...

NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results PR Newswire SAN DIEGO, May 4, 2023 SAN DIEGO , May 4, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2023 results on Wednesday, May 10, 2023 , after the close of the market. NuVasive will hold a conference call on...

NuVasive to Participate in Upcoming Global Spine Conferences PR Newswire SAN DIEGO, April 11, 2023 SAN DIEGO , April 11, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its continued participation at various global conferences throughout April and May. "Our participation in spine conferences around the world reflects our belief in...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED). Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients PR Newswire SAN DIEGO, March 20, 2023 SAN DIEGO , March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its Precice...